HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Over The Counter 26 July 2022: Global Self-Care Trends With J&J Self-Care R&D Lead Adam Ricciardone

Executive Summary

In this episode, HBW Insight speaks to Johnson & Johnson Self-Care R&D lead Adam Ricciardone about four macro trends the company is observing worldwide: total wellness, sustainability, demographic shifts and the “techceleration” of self-care. Ricciardone talks about J&J's latest self-care technologies and why non-western countries, particularly in Asia, are quicker to adopt new consumer healthcare trends. 


Further Reading

Self-Care Saving Taxpayers $120bn Per Year, Could Increase To $180bn By 2030

IQVIA Consumer Health: Brands Can Beat Inflation, But Only If OTC Firms Raise Their Game

AESGP Annual Meeting, Day 2 (Part 1): The Future For Europe’s Self-Care Industry Is Bright And Digital

J&J Consumer Health Q2 Results No Help For Avoiding Lowering Full-Year Guidance Again

J&J: Inflationary Pressures ‘Here To Stay’ With Impact Likely Into 2023

Further Listening

These and all other podcasts are available on the Informa Pharma Intelligence channel on Apple PodcastsGoogle PodcastsSoundCloud and TuneIn - and also now on Spotify Podcasts - and via smart speakers if one of these platforms has been set up as your default podcast provider. 

Over The Counter Theme Music:

Modern Chillout by penguinmusic.

Copyright 2021 Licensed under a commercial Pixabay License.

 

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152757

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel